OPEN END TURBO CALL WARRANT - AMGEN | Market Closed - Deutsche Boerse AG 10:56:17 28/06/2024 pm IST | ||
| 0.89 EUR | +1.14% |
|
| Current month | +8.54% | ||
| 1 month | +15.58% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 0.89 | +1.14% |
| 27/24/27 | 0.88 | -2.22% |
| 26/24/26 | 0.9 | -5.26% |
| 25/24/25 | 0.95 | +5.56% |
| 24/24/24 | 0.9 | +4.65% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 10:56 pm IST
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UH13WL |
| ISIN | DE000UH13WL2 |
| Date issued | 03/09/2021 |
| Strike | 218 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.37 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.07 € |
|---|---|
| Lowest since issue | 0.056 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
